Agilent Technologies, Inc. $A Shares Bought by Daiwa Securities Group Inc.

by · The Markets Daily

Daiwa Securities Group Inc. grew its stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 52.4% in the fourth quarter, HoldingsChannel reports. The fund owned 74,247 shares of the medical research company’s stock after buying an additional 25,515 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Agilent Technologies were worth $10,103,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Gabelli Funds LLC boosted its holdings in Agilent Technologies by 1.1% in the 3rd quarter. Gabelli Funds LLC now owns 6,620 shares of the medical research company’s stock worth $850,000 after acquiring an additional 74 shares during the period. Fiduciary Trust Co boosted its holdings in Agilent Technologies by 1.6% in the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after acquiring an additional 77 shares during the period. NorthCrest Asset Manangement LLC boosted its holdings in Agilent Technologies by 1.6% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 5,082 shares of the medical research company’s stock worth $726,000 after acquiring an additional 79 shares during the period. Freestone Capital Holdings LLC boosted its holdings in Agilent Technologies by 2.0% in the 4th quarter. Freestone Capital Holdings LLC now owns 4,218 shares of the medical research company’s stock worth $574,000 after acquiring an additional 84 shares during the period. Finally, Cibc World Market Inc. boosted its holdings in Agilent Technologies by 0.3% in the 3rd quarter. Cibc World Market Inc. now owns 29,076 shares of the medical research company’s stock worth $3,732,000 after acquiring an additional 85 shares during the period.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. UBS Group decreased their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Thursday, February 26th. HSBC decreased their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Wednesday. TD Cowen upped their price target on Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Finally, Wells Fargo & Company reduced their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, May 28th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $161.71.

View Our Latest Analysis on Agilent Technologies

Agilent Technologies Price Performance

Shares of NYSE A opened at $135.51 on Friday. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The business’s fifty day moving average price is $118.35 and its two-hundred day moving average price is $128.35. The firm has a market capitalization of $38.27 billion, a PE ratio of 27.21, a P/E/G ratio of 2.41 and a beta of 1.26.

Agilent Technologies (NYSE:A – Get Free Report) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.84 billion during the quarter, compared to analysts’ expectations of $1.80 billion. During the same quarter last year, the business posted $1.31 earnings per share. The company’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts expect that Agilent Technologies, Inc. will post 5.99 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Featured Articles

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).